Safety of Lumiracoxib in Patients With Osteoarthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
This safety study evaluated the incidence of gastrointestinal adverse events and edema in patients with osteoarthritis treated with lumiracoxib and rofecoxib as comparator
Epistemonikos ID: 136180bacf54a8321365581a3bb85c88962e80af
First added on: May 04, 2024